What's New at CBER

You are subscribed to  What's New at CBER for the U.S. Food & Drug Administration (FDA)

What's New Today

The following links have been updated recently:

Posted: 01/04/2024

• CBER Cures Vacancy Announcement - Physician (Team Lead), AD-0602-Band D, Office of Vaccines Research and Review (OVRR), Division of Clinical and Toxicology Review (DCTR)

Workshops, Meetings & Conferences

January

• WCBP Symposium 2024
  This Symposium addresses the role of current and emerging CMC analytical technology among evolving US and international regulatory perspectives.
  January 23 - 25, 2024

February

• Public Workshop: Biomarker-driven Drug Development for Allergic Diseases and Asthma; Public Workshop
  February 22, 2024

Draft Guidance Now Available: Potency Assurance for Cellular and Gene Therapy ProductsClick to edit this heading.

On December 28, 2023, FDA announced the availability of the draft guidance, Potency Assurance for Cellular and Gene Therapy Products. For a high-level overview of this guidance document, please view this recorded webinar. Comments for this draft guidance can be submitted online or via mail through March 27, 2024.